These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3910768)

  • 41. Effect of captopril on plasma prolactin in patients with essential hypertension.
    Saito I; Takeshita E; Hayashi S; Takenaka T; Murakami M; Saruta T; Nagano S; Sekihara T
    Angiology; 1990 May; 41(5):377-81. PubMed ID: 2192585
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Haemodynamic and clinical effects of long-term treatment of essential hypertension with captopril.
    Ricciardelli B; Volpe M; Trimarco B; De Luca N; Cuocolo A; Sacca' L; Condorelli M
    Eur Heart J; 1983 Jul; 4(7):496-501. PubMed ID: 6414815
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Captopril and common carotid blood flow in patients with essential hypertension--a review.
    Safar ME; Bouthier JA; Laurent SM; Simon AC
    Postgrad Med J; 1986; 62 Suppl 1():31-3. PubMed ID: 3317339
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The role of captopril as single therapy in hypertension and angina pectoris.
    Akhras F; Jackson G
    Int J Cardiol; 1991 Nov; 33(2):259-66. PubMed ID: 1743787
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antihypertensive effects of parenteral nicardipine alone and in combination with captopril.
    Conrad KA; Fagan TC; Mayshar P; Davis TP; Johnson DG
    Clin Pharmacol Ther; 1987 Jul; 42(1):113-8. PubMed ID: 3297467
    [TBL] [Abstract][Full Text] [Related]  

  • 46. No sex-related pharmacokinetic and pharmacodynamic differences of captopril.
    Massana E; Barbanoj MJ; Moros C; Morte A; Gich I; Jané F
    Pharmacol Res; 1997 Jul; 36(1):41-7. PubMed ID: 9368913
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differential exercise effects of captopril and nadolol in patients with essential hypertension.
    Kostis JB; Shindler DM; Moreyra AE; Ruddy MC; Schneider S; Cosgrove N
    Angiology; 1992 Aug; 43(8):647-52. PubMed ID: 1632567
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacodynamic and humoral effects of single intravenous doses of captopril in normal subjects.
    Nussberger J; Waeber G; Bidiville J; Waeber B; Brunner HR
    Clin Exp Hypertens A; 1987; 9(2-3):345-9. PubMed ID: 3301079
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Regression of structural vascular changes in hypertensives after captopril treatment.
    Novo S; Abrignani MG; Pinto A; Strano A
    Eur Heart J; 1992 Aug; 13(8):1135-7. PubMed ID: 1505564
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Captopril: pharmacokinetics, antihypertensive and biological effects in hypertensive patients.
    Richer C; Giroux B; Plouin PF; Maarek B; Giudicelli JF
    Br J Clin Pharmacol; 1984 Mar; 17(3):243-50. PubMed ID: 6324834
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Influence of captopril on hemodynamics of human placenta in vitro].
    Ziółkowski C; Semczuk-Sikora A; Skoczyński M; Semczuk M
    Ginekol Pol; 2000 Aug; 71(8):854-8. PubMed ID: 11082936
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Changes in the hemodynamics and cardiac function of hypertension patients on moderate limited consumption of table salt].
    Bakhshaliev AB; Gadzhiev RF; Lan'shina OE
    Ter Arkh; 1988; 60(12):21-6. PubMed ID: 3073540
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of ketoprofen on blood pressure, endocrine and renal responses to chronic dosing with captopril in patients with essential hypertension.
    Cusson JR; du Souich P; Le Morvan P; Thibault G; Phillips R; Milot A; Larochelle P
    Blood Press; 1992 Oct; 1(3):162-7. PubMed ID: 1345049
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Captopril and opiate antagonism in essential hypertension.
    Ajayi AA; Rubin PC; Reid JL
    Br J Clin Pharmacol; 1986 May; 21(5):543-5. PubMed ID: 3521691
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparative effects on blood pressure and regional hemodynamics of nicardipine and captopril.
    Mancini M; De Simone G; Celentano A; Ferrara LA
    J Cardiovasc Pharmacol; 1991 Dec; 18(6):807-12. PubMed ID: 1725891
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Haemodynamic profile of captopril treatment in various forms of hypertension.
    de Bruyn JH; Man in't Veld AJ; Wenting GJ; Derkx FH; Schalekamp MA
    Eur J Clin Pharmacol; 1981; 20(3):163-8. PubMed ID: 7026256
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacokinetics and pharmacodynamics of captopril in patients undergoing continuous ambulatory peritoneal dialysis.
    Fujimura A; Kajiyama H; Ebihara A; Iwashita K; Nomura Y; Kawahara Y
    Nephron; 1986; 44(4):324-8. PubMed ID: 3025754
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Acute and chronic effects of captopril on bicyclo-PGEm, the stable bicyclic end product of prostaglandin E2 in essential hypertension.
    Stanek B; Silberbauer K
    Nephron; 1986; 44(1):40-5. PubMed ID: 3528880
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effect of captopril on peripheral hemodynamics in patients with essential hypertension: comparison between oral and sublingual administration.
    Longhini C; Ansani L; Musacci G; Mele D; Vaccari M; Baracca E; Sgobino P
    Cardiovasc Drugs Ther; 1990 Jun; 4(3):751-4. PubMed ID: 2076385
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacokinetics of a new angiotensin I converting enzyme inhibitor (alacepril) after oral dosing in fasting or fed states.
    Onoyama K; Hirakata H; Tsuruda H; Ohchi N; Tomooka S; Motomura K; Omae T; Hayashi K; Fujishima M
    Clin Pharmacol Ther; 1985 Oct; 38(4):462-8. PubMed ID: 3899460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.